Background: Radiofrequency ablation (RFA) is a minimally invasive technique that can eradicate malignant disease in the liver, including metastatic disease from gynecological primary tumors.
Case: An 81-year-old female underwent percutaneous RFA for a solitary intrahepatic metastatic lesion that was her only known site of disease 2 years after definitive surgery and chemotherapy for stage IIIC ovarian adenocarcinoma. She was able to start systemic chemotherapy 1 week after RFA, and continues to be free of disease in the liver.
Conclusion: RFA can be a useful tool for treating liver tumors in patients who would otherwise not be candidates for liver resection. Its advantages include minimal invasiveness, low morbidity, and rapid recovery for expeditious treatment with systemic chemotherapy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ygyno.2004.01.041 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!